NCT06323291

Brief Summary

This Pilot Study will evaluate a 12-week pilot program that offers digital health coaching for individuals with pancreatic cancer and their caregivers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P50-P75 for early_phase_1 pancreatic-cancer

Timeline
Completed

Started Apr 2024

Shorter than P25 for early_phase_1 pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2025

Completed
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.2 years

First QC Date

March 14, 2024

Last Update Submit

February 5, 2026

Conditions

Keywords

PancreasPancreatic CancerCaregiver

Outcome Measures

Primary Outcomes (4)

  • Recruitment Rate

    Measured by ≥ 50% of eligible participants recruited.

    Up to 12 Months

  • Participant Acceptance of the Digital Health Coaching Program

    Measured by ≥ 70% of participant rating of the intervention as satisfactory. 4 item scale (score range 0-20) will be utilized.

    Up to 12 Weeks

  • Participant Ease of Usability of the Digital Health Coaching Program

    Measured by ≥ 70% of participant rating the mobile application as easy-to-use for scheduling coaching visits. 4 item scale (score range 0-20) will be utilized.

    Up to 12 Weeks

  • Feasibility of Utilizing the Digital Health Coaching Program

    Measured by ≥ 70% of participant rating of being likely to utilize the intervention. 4 item scale (score range 0-20) will be utilized.

    Up to 12 Weeks

Study Arms (2)

Digital Health Coaching for Pancreatic Cancer Patients

OTHER

Initial in-person and/or virtual supportive care, social work, and dietitian consultation within 4 weeks of diagnosis and/or 3 weeks of study enrollment.

Behavioral: Coaching Sessions

Digital Health Coaching for Caregivers

OTHER

Initial in-person and/or virtual supportive care, social work, and dietitian consultation within 4 weeks of diagnosis and/or 3 weeks of study enrollment.

Behavioral: Coaching Sessions

Interventions

Enrolled participants will set up an account through a secure and encrypted web portal managed by Osara Health. Coaches will follow-up with their designated patients and/or caregivers to schedule individual coaching sessions via phone, text, or email depending on the participant's communication preference. Participants will have an initial coaching consultation by phone to go over the purpose and structure of coaching sessions. Participants will then have an additional 3-4 coaching sessions (depending on time availability and need) to discuss symptom management, nutrition and exercise, sleep, and mindfulness. Participants will receive content for each of the modules via email.

Digital Health Coaching for CaregiversDigital Health Coaching for Pancreatic Cancer Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older.
  • Participant must have a pancreatic cancer diagnosis or be a caregiver such as a friend or spouse.
  • Participant must be planning to receive treatment and/or care management at Moffitt Cancer Center.
  • Participant must be able to speak and read English.
  • Participant must be able to provide informed consent.

You may not qualify if:

  • Documented or observable psychiatric or neurological disorder that would interfere with study participation such as severe dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moffitt Cancer Center

Tampa, Florida, 33612, United States

Location

Related Links

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Amir Alishahi Tabriz, MD, PhD

    Moffitt Cancer Center

    PRINCIPAL INVESTIGATOR
  • Pamela Hodul, MD

    Moffitt Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 14, 2024

First Posted

March 21, 2024

Study Start

April 1, 2024

Primary Completion

May 26, 2025

Study Completion

May 26, 2025

Last Updated

February 9, 2026

Record last verified: 2026-02

Locations